| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000033228 |
| Receipt No. | R000037889 |
| Official scientific title of the study | Association of Lecithin-cholesterol Acyltransferase Activity and Low-density Lipoprotein Heterogeneity with Atherosclerotic Cardiovascular Risk: A Pilot Longitudinal Study |
| Date of disclosure of the study information | 2018/07/02 |
| Last modified on | 2018/12/10 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Association of Lecithin-cholesterol Acyltransferase Activity and Low-density Lipoprotein Heterogeneity with Atherosclerotic Cardiovascular Risk: A Pilot Longitudinal Study | |
| Title of the study (Brief title) | LCAT activity and LDL-particle size | |
| Region |
|
|
| Condition | ||
| Condition | The criterion for patient registration was the presence of one or more risk factors for atherosclerosis. | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | This study was designed as a hospital-based longitudinal study to investigate the relationship between the change in LCAT activity and change in LDL-particle size in subjects who were available for additional measurements one year after their participation in our previous study. |
| Basic objectives2 | Others |
| Basic objectives -Others | using a longitudinal study, we attempted to clarify hypothesis that elevation of LCAT activity is associated with an increase in the serum levels of TRL-related markers, involved in TG metabolism (i.e. TG, remnant particle-like cholesterol [RLP-C], apolipoprotein (apo) B, apo C-2, and apo C-3), and is thus involved in reduction of the LDL-particle size. |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | The primary endo point was to evaluate the association of the absolute change in
LCAT activity with the change in LDL particle size, using a multilogistic regression analysis |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | The criterion for patient registration was the presence of one or more risk factors for atherosclerosis. | |||
| Key exclusion criteria | hepatic dysfunction (alanine aminotransferase and aspartate aminotransferase more than 2 times the upper limit of the normal values), known malignant disease, refusal to provide consent for participation in the study, or the diagnosis of acute coronary syndrome within 3 months prior to the study, and/or serum TG 400 mg/dL. | |||
| Target sample size | 400 | |||
| Research contact person | |
| Name of lead principal investigator | Shigemasa Tani |
| Organization | Nihon University Hospital |
| Division name | Department of Cardiology |
| Address | 1-6 Kanda-Surugadai, Chiyoda-ku, Tokyo , Japan |
| TEL | 03-3293-1711 |
| tanishigem@yahoo.co.jp | |
| Public contact | |
| Name of contact person | Shigemasa Tani |
| Organization | Nihon University Hospital |
| Division name | Department of Cardiology |
| Address | 1-6 Kanda-Surugadai, Chiyoda-ku, Tokyo , Japan |
| TEL | 03-3293-1711 |
| Homepage URL | |
| tanishigem@yahoo.co.jp | |
| Sponsor | |
| Institute | Department of Cardiology, Nihon University Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Department of Cardiology, Nihon University Hospital |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| URL releasing results | |
| Results | |
| Other related information | Collecting patient data. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000037889 |